Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism
茶碱治疗假性甲状旁腺功能减退症的 2 期研究
基本信息
- 批准号:10775196
- 负责人:
- 金额:$ 21.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-24 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAgeAwardBody Weight decreasedBody mass indexCategoriesChildChildhoodClinicClinical ResearchClinical TrialsComplementContinuous Glucose MonitorDataDevelopmentEnvironmentEthnic OriginEvaluationExercise ToleranceFundingFutureGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGenderGeneral PopulationGenetic DiseasesGlucoseGlucose tolerance testGoalsGrantHeterozygoteHuman Subject ResearchHyperglycemiaImpaired cognitionImpairmentIndividualInfrastructureInsulinInsulin ResistanceLearningLifeLightManuscriptsMaster of ScienceMeasurementMeasuresMentorsMentorshipMetabolicMetabolismMonitorMutationNon-Insulin-Dependent Diabetes MellitusOGTTObesityObstructive Sleep ApneaParentsParticipantPhysical activityPhysiciansPopulationPopulation DecreasesPositioning AttributePrediabetes syndromePseudohypoparathyroidismRaceRare DiseasesResearchResearch PersonnelResearch TrainingResourcesRiskScientistSignal TransductionSiteSleepSleep DisordersTechniquesTechnologyTestingTheophyllineTimeTrainingTranslational ResearchTravelUnited States National Institutes of HealthWalkingWritingactigraphycareercareer developmentclinical investigationcohortearly-onset obesityexercise capacitygene repressionglucose tolerancehormone resistanceimprovedinsightmetabolic abnormality assessmentmonitoring devicepatient orientedphase 2 studypoor sleepprimary outcomeremote assessmentremote monitoringresponsible research conductsecondary outcomesedentaryskillssleep patterntooltraining opportunitywearable deviceyoung adult
项目摘要
PROJECT SUMMARY
Pseudohypoparathyroidism type 1A (PHP1A) is a rare, genetic disorder caused by impaired stimulatory
G protein (Gsα) signaling through downregulation of the gene, GNAS. PHP1A results in multi-hormone
resistance and early-onset obesity. The parent R01 (PI: Shoemaker, R01DK118407) is evaluating whether
theophylline decreases body mass index and improves glucose tolerance in PHP1A. As part of this clinical
trial, oral glucose tolerance tests and 6-minute walk tests are being evaluated to assess glycemia, insulin
resistance, and activity.
The overarching scientific goal of this supplemental study is to evaluate glycemia, activity, and sleep
using remote, wearable technology including continuous glucose monitors (CGM) and actigraphy. The primary
objectives of this study are to compare percent hyperglycemia on CGM, physical activity via actigraphy, and
sleep duration via actigraphy in individuals with PHP1A and matched controls. Secondary outcomes will
evaluate these “real-world” parameters with study assessments including OGTT and 6-minute walk tests.
The overarching career development goal of this study is to provide comprehensive training that will
enable the applicant to become an independent physician-scientist with a clinical and translational research
career focusing on insulin resistance and dysglycemia. The applicant will learn critical skills in human subjects’
research through both the completion of this study and the Master of Science in Clinical Investigation. She will
extend her understanding of metabolic parameters, learn to utilize remote monitoring devices in clinical
research, and gain expertise in human subjects’ research in rare diseases. This experiential and didactic
learning will be in conjunction with continued professional development, grant writing, manuscript writing, and
training in responsible conduct of research. The applicant’s primary mentor, Dr. Ashley Shoemaker, and
mentorship team are experts in glucose and insulin metabolism, the evaluation of activity, and clinical research
in rare diseases. They have provided the applicant exceptional mentorship thus far, while on the NIH F32
award (F32DK128970, August 2021). Vanderbilt University Medical Center (VUMC) provides an outstanding
research environment with abundant resources and training opportunities for young investigators.
项目摘要
假性甲状旁腺功能减退1A型(PHP1A)是一种罕见的遗传性疾病,由受损的刺激性
G蛋白(Gsα)通过下调基因GNAS进行信号传导。PHP1A导致多激素
抵抗力和早发性肥胖。父R01(PI:Shoemaker,R01DK118407)正在评估是否
茶碱降低PHP1A的体重指数并改善葡萄糖耐量。在本次临床
一项试验,口服葡萄糖耐量试验和6分钟步行试验正在进行评估,以评估胰岛素,
阻力和活动。
这项补充研究的首要科学目标是评估睡眠,活动和睡眠
使用远程可穿戴技术,包括连续葡萄糖监测仪(CGM)和活动记录仪。主
本研究的目的是比较CGM上的高血糖百分比,通过体动记录仪进行的体力活动,
PHP1A患者和对照组通过体动记录仪记录的睡眠持续时间。次要结局将
通过OGTT和6分钟步行试验等研究评估来评估这些“真实世界”参数。
这项研究的总体职业发展目标是提供全面的培训,
使申请人成为一名独立的医生,科学家与临床和转化研究
主要研究胰岛素抵抗和糖尿病。申请人将学习人类受试者的关键技能。
通过完成这项研究和临床研究理学硕士研究。她将
扩展她对代谢参数的理解,学习在临床中使用远程监测设备
研究,并获得人类受试者在罕见疾病研究方面的专业知识。这种经验和说教
学习将与持续的专业发展,赠款写作,手稿写作,
培训负责任的研究行为。申请人的主要导师,阿什利舒梅克博士,
导师团队是葡萄糖和胰岛素代谢,活动评估和临床研究方面的专家
在罕见疾病中。到目前为止,他们为申请人提供了特殊的指导,而在NIH F32
奖项(F32DK128970,2021年8月)。范德比尔特大学医学中心(VUMC)提供了一个杰出的
为年轻研究人员提供丰富的资源和培训机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashley Hall Shoemaker其他文献
Ashley Hall Shoemaker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashley Hall Shoemaker', 18)}}的其他基金
Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism
茶碱治疗假性甲状旁腺功能减退症的 2 期研究
- 批准号:
10553088 - 财政年份:2021
- 资助金额:
$ 21.64万 - 项目类别:
Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism
茶碱治疗假性甲状旁腺功能减退症的 2 期研究
- 批准号:
10322452 - 财政年份:2021
- 资助金额:
$ 21.64万 - 项目类别:
Early Onset Obesity and Cognitive Impairment in Pseudohypoparathyroidism
假性甲状旁腺功能减退症的早发性肥胖和认知障碍
- 批准号:
8917947 - 财政年份:2014
- 资助金额:
$ 21.64万 - 项目类别:
Early Onset Obesity and Cognitive Impairment in Pseudohypoparathyroidism
假性甲状旁腺功能减退症的早发性肥胖和认知障碍
- 批准号:
9313247 - 财政年份:2014
- 资助金额:
$ 21.64万 - 项目类别:
Early Onset Obesity and Cognitive Impairment in Pseudohypoparathyroidism
假性甲状旁腺功能减退症的早发性肥胖和认知障碍
- 批准号:
9261103 - 财政年份:2014
- 资助金额:
$ 21.64万 - 项目类别:
Early Onset Obesity and Cognitive Impairment in Pseudohypoparathyroidism
假性甲状旁腺功能减退症的早发性肥胖和认知障碍
- 批准号:
9091517 - 财政年份:2014
- 资助金额:
$ 21.64万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Directed Grant